Home > ASME Articles > Integrating Buprenorphine into formerly "drug-free" programs
This article, while not based on NIDA Clinical Trials Network research, may be of interest to those following the CTN’s work related to buprenorphine for opiate use disorder treatment.
Semi-structured interviews (N=15) were conducted with counseling and medical staff; respondents were predominantly African American (n=11) and female (n=12). Two different delivery models were involved:
Co-located program staff also reported less communication between medical and counseling staff, which contributed to uncertainty about proper dosing and concerns about potential for medication diversion.
Conclusions: Clinics that shift from drug-free to incorporating buprenorphine maintenance should consider which model of care they wish to adapt and how best to train staff and structure communication. Team-based approaches being used in primary care settings offer models of integration that have the potential to translate into more specialty care settings, like previously drug-free treatment centers. Future research can build from these results and offer short- and long-term patient outcome data to support the effectiveness of various models and gradients of team-based integration in substance abuse treatment.